GR20010100450A - Immunity-enhancing melamine - Google Patents
Immunity-enhancing melamineInfo
- Publication number
- GR20010100450A GR20010100450A GR20010100450A GR2001100450A GR20010100450A GR 20010100450 A GR20010100450 A GR 20010100450A GR 20010100450 A GR20010100450 A GR 20010100450A GR 2001100450 A GR2001100450 A GR 2001100450A GR 20010100450 A GR20010100450 A GR 20010100450A
- Authority
- GR
- Greece
- Prior art keywords
- immunity
- immunogen
- melamin
- immune response
- melamine
- Prior art date
Links
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 title abstract 3
- 229920000877 Melamine resin Polymers 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 2
- 229940056960 melamin Drugs 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000001851 biosynthetic effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
he present invention relates to the ability of melamin to act as adjuvant, which enhances the immune response in a vertebrate host to a selected immunogen. The method comprises the administration of an immunogen with an effective quantity of natural, synthetic or biosynthetic melamin to enhance the immune response against the immunogen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20010100450A GR20010100450A (en) | 2001-09-25 | 2001-09-25 | Immunity-enhancing melamine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20010100450A GR20010100450A (en) | 2001-09-25 | 2001-09-25 | Immunity-enhancing melamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR20010100450A true GR20010100450A (en) | 2003-05-19 |
Family
ID=29559693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010100450A GR20010100450A (en) | 2001-09-25 | 2001-09-25 | Immunity-enhancing melamine |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR20010100450A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995008335A1 (en) * | 1993-09-24 | 1995-03-30 | Maurizio Zanetti | Treatment of hiv infection with humic acid |
-
2001
- 2001-09-25 GR GR20010100450A patent/GR20010100450A/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995008335A1 (en) * | 1993-09-24 | 1995-03-30 | Maurizio Zanetti | Treatment of hiv infection with humic acid |
Non-Patent Citations (2)
| Title |
|---|
| BROEKHUYSE R M ET AL: "Experimental autoimmune anterior uveitis (EAAU): III. Induction by immunization with purified uveal and skin melanins.", EXPERIMENTAL EYE RESEARCH, vol. 56, no. 5, 1993, pages 575 - 583, XP001086462, ISSN: 0014-4835 * |
| KAYA M ET AL: "AUGMENTATION OF INTRAOCULAR INFLAMMATION BY MELANIN", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 33, no. 3, 1992, pages 522 - 531, XP008006240, ISSN: 0146-0404 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004032829A3 (en) | Immunostimulatory compositions and methods of stimulating an immune response | |
| MXPA03011135A (en) | Mutant forms of cholera holotoxin as an adjuvant. | |
| WO2004030608A3 (en) | Nanoemulsion vaccines | |
| WO2003015694A3 (en) | Agents for enhancing the immune response | |
| IS4518A (en) | New vaccine formulation | |
| AU3113902A (en) | Thiazolyl inhibitors of tec family tyrosine kinases | |
| WO2004007679A3 (en) | Dendritic cell pontentiation | |
| DE122010000042I1 (en) | Solubilization of capsular polysaccharides | |
| MY139523A (en) | Ziprasidone composition and synthetic controls | |
| PT1326633E (en) | Composition comprising immunogenic microparticles | |
| MXPA03006587A (en) | Chemokines as adjuvants of immune response. | |
| WO2002094002A3 (en) | Cultivated agarwood | |
| DK1076566T3 (en) | Attenuated salmonella mutants that constructively express the Vi antigen | |
| WO2006065553A3 (en) | Glycoconjugate vaccines containing peptidoglycan | |
| EA199900069A1 (en) | VACCINE COMPOSITION AGAINST MALARIA | |
| WO2004005476A3 (en) | Nucleic acid compositions for stimulating immune responses | |
| WO2006062807A3 (en) | Compositions with enhanced immunogenicity | |
| WO2003051288A3 (en) | Mycobacterial vaccine | |
| GB2364642B (en) | Compositions for enhancing the immune response | |
| GR20010100450A (en) | Immunity-enhancing melamine | |
| NO20062579L (en) | Compositions comprising melittin-derived peptides and methods for enhancing immune responses to malantigens | |
| IL139832A0 (en) | Therapeutic compositions that produce an immune response by altering the antigen | |
| WO2005046571A3 (en) | Lactoferrin as an adjuvant in cancer vaccines | |
| GB2390811B (en) | Therapeutic compositions that alter the immune response | |
| WO2002045738A3 (en) | Vaccine composition containing transforming growth factor alpha |